New Clinical Data Reveals Long-Term Success of Oral HAE Treatment Deucrictibant - Stock Titan
2 days ago • Google News
Pharvaris BV (PHVS)
US$ 19.416.07%
Price Chart
Key Statistics
Market Cap
$ 893.69M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
84.81K
52W High
$ 25.50
52W Low
$ 11.51
Dividend Yield
0.00%
Beta
-2.85
Technicals
50-Day MA
15.6198
200-Day MA
18.1699
52 Week High
25.4985
52 Week Low
11.51
About PHVS
Pharvaris N.V.
Employees
108
Headquarters
Zug, Switzerland
CEO
Mr. Berndt Axel Edvard Modig CPA, M.B.A.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg